Dr. Reddy's Laboratories Limited (RDY) Q2 2027 Earnings Call TranscriptSeeking Alpha · 1 day ago
Dr. Reddy's Laboratories Q2 Earnings Call HighlightsMarketBeat · 1 day ago
Dr. Reddy’s Laboratories (NYSE:RDY) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?Defense World · Oct 15, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYPRNewsWire · Sep 24, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYGlobeNewsWire · Sep 22, 2026
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in IndiaReuters · Sep 17, 2026Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions.
| Date | Est. | Actual | |
|---|---|---|---|
| Oct 23, 2026 | $0.10 | $0.12 | Beat |
| Jul 21, 2026 | $0.09 | $0.06 | Miss |
| May 11, 2026 | $0.09 | $0.06 | Miss |
| Jan 20, 2026 | $0.16 | $0.16 | Beat |
| Oct 24, 2025 | $0.18 | $0.19 | Beat |
| Jul 23, 2025 | $0.18 | $0.20 | Beat |